Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mrfox
    Senior Member
    • Aug 2010
    • 103

    #1

    Tumor fraction and CNV: a loop?

    I am trying to detect somatic CNV using matched tumor/normal exome sequencing data.

    I found that popular tools such as EXCAVATOR, ExomeCNV etc require tumor fraction or cellularity as an input parameter.

    At the same time, tumor fraction estimation tools such as THetA require CNV result as input.

    Could anyone recommend a simple tool that could estimate tumor fraction without using CNV data, or a CNV detection tool with built-in function to estimate tumor fraction?
  • stefanoberri
    Member
    • Jan 2010
    • 35

    #2
    Hi.

    It is partially a loop. We provided a solution with CNAnorm a tool described in this paper

    but we awknoledge that there is not a single solution to the problem

    Imagine your tumour is 67% pure, triploid for chr1 (2/3 of cells have the amplification) and diploid everywhere else.

    This will give you the very same data when the tumour is 50% pure, esaploid for chr1 and tetraploid everywhere else.

    If you have more complex pattern of amplifications and BAllele data, your model could still come up to a decent guess. If you have heterogeneity the problem becomes more difficult.

    However, if you know the various copy number states, detecting tumour content (and even heterogeneity) becomes easy or at least possible. Similarly, if you have tumour content, detecting copy number states accurately becomes possible.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...